Abstract
AMP was evaluated for its efficacy against herpes simplex virus type 2 genital infections in guinea pigs. Vaginally infected animals were treated twice a day with AMP at 50 mg/kg per dose for 2 weeks. Subcutaneous doses were started 10 weeks postinfection. AMP treatment did not reduce the number of animals with recrudescent episodes when compared with saline-treated controls. In addition, AMP treatment did not reduce either the number of lesions or the duration of the recrudescent episodes which did develop. These results suggest that AMP has no effect on recrudescent herpes simplex virus type 2 vaginal infections.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blue W. T., Winland R. D., Stobbs D. G., Kirksey D. F., Savage R. E. Effects of adenosine monophosphate on the reactivation of latent herpes simplex virus type 1 infections of mice. Antimicrob Agents Chemother. 1981 Oct;20(4):547–548. doi: 10.1128/aac.20.4.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sklar S. H., Wigand J. S. Herpes zoster. Br J Dermatol. 1981 Mar;104(3):351–352. doi: 10.1111/j.1365-2133.1981.tb00964.x. [DOI] [PubMed] [Google Scholar]